Schedule 13G ownership disclosure

Rich Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 76303T308

Event date: 2017-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
126,023,000
Percent of class
9.6390%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001078782-17-000056
Form type
SC 13G/A
Filer
LG CAPITAL FUNDING, LLC
CIK
CIK 1585346
Filed
Jan 12, 2017
Reporting period
Jan 10, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub